
Y-mAbs Therapeutics Inc
NASDAQ:YMAB

Relative Value
The Relative Value of one
YMAB
stock under the Base Case scenario is
9.99
USD.
Compared to the current market price of 4.6 USD,
Y-mAbs Therapeutics Inc
is
Undervalued by 54%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
